Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

SB 1179 (2023-2024)

https://ontology.bommaritollc.com/id/01a0d569-1e59-73ae-930d-d384c6c80ad4

adms:identifier	mi-legislature-measure 2023-2024/SB/1179
dcterms:temporal	Michigan Legislature, 2023-2024 session
primary sponsor	Sam Singh
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2024-SB-1179 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2024-SB-1179 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2024-SB-1179 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2024-SB-1179
schema:legislationChanges	1978 PA 368
schema:legislationIdentifier	SB 1179
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: pharmaceuticals; drug manufacturers from engaging in certain conduct with pharmacies participating with a 340B program; prohibit. Amends 1978 PA 368 (MCL 333.1101 - 333.25211 ) by adding sec. 17757c.en
schema:sponsor	Sam Singh
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2024-SB-1179
skos:prefLabel	SB 1179 (2023-2024)en
status	in committee
status date	2024-12-13xsd:date